title: Thromboprophylaxis in antiphospholipid syndrome pregnancies with previous cerebral arterial thrombotic events: is warfarin preferable?
authors.forename: B J
authors.initials: BJ
authors.lastname: Hunt
authors.forename: M
authors.initials: M
authors.lastname: Khamashta
authors.forename: L
authors.initials: L
authors.lastname: Lakasing
authors.forename: F M
authors.initials: FM
authors.lastname: Williams
authors.forename: C
authors.initials: C
authors.lastname: Nelson Piercy
authors.forename: S
authors.initials: S
authors.lastname: Bewley
authors.forename: G R
authors.initials: GR
authors.lastname: Hughes
mesh_terms: D000328:Adult; D000925:Anticoagulants / Q000627:therapeutic use*; D016736:Antiphospholipid Syndrome; D005260:Female; D006801:Humans; D002542:Intracranial Embolism and Thrombosis / Q000150:complications* / Q000517:prevention & control*; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000188:drug therapy*; D014859:Warfarin / Q000627:therapeutic use*
chemical_list: D000925:Anticoagulants; D014859:Warfarin